Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
My Action Plan as CEO (Next 48 Hours) Core Decision and Overarching Reasoning: I will treat this as a confirmed safety signal requiring urgent action. Patient safety is non-negotiable—ethically (primum non nocere and responsibility to 4 million patients), legally (FDA regulations under 21 CFR 314.80 require reporting…Read the full answer
My north star: We disclose—fast, fully, and on our terms. The “wait for more data” option is a mirage. It exposes the company to criminal liability under FDA adverse-event reporting rules, potential DOJ investigation, securities fraud charges, and derivative litigation that could destroy the firm.Read the full answer